Amneal Pharmaceuticals (AMRX) PT Raised to $11 at Barclays
Tweet
Share
E-mailGet Alerts AMRX Hot Sheet
Price: $18.15 +5.10%
Rating Summary:
6 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays analyst Balaji Prasad raised the price target on Amneal Pharmaceuticals (NASDAQ: AMRX) to $11.00 (from $10.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Travel Food Services (TRAVELFO:IN) PT Raised to INR1,600 at ICICI Securities
- Honasa Consumer Ltd (HONASA:IN) PT Raised to INR720 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
